In AD patients, MALAT1 expression increased, and its target expression, miR-125b, decreased. MALAT1 and miR-125b may be involved in disease management through interaction with FOXQ1, PTGS2, and CDK5 genes. Here, PTGS2 is linked to Alzheimer disease.